Only one Manhattan acute care hospital obtained a Top A grade in the Spring 2018 Leapfrog Hospital Safety Grades: the NYC Health Hospitals – Metropolitan in East Harlem.
Most of the others, NYU Langone Medical Center, NYC Health + Hospitals / Bellevue, Mount Sinai West, New York-Presbyterian , Northwell Health System – Lenox Hill Hospital, The Mount Sinai Hospital, NYC Health + Hospitals – Harlem and Mount Sinai St. Luke’s all obtained a C. Mount Sinai Beth Israel had the worst Manhattan score with a D on a scale of A for the best to F for the worst.
The Leapfrog Hospital Safety Grades is a nationwide bi-annual rating that focuses on acute care hospital errors, accidents, injuries and infections that collectively are the third leading cause of death in the United States. Based on the data provided by the report here is what we found for Manhattan hospitals.
More than twenty years ago, a medication was developed that can save lives and reduce the disabling impacts of a stroke. Known as tissue plasminogen activator (or “T.P.A.”), this medication is now considered the gold standard for the treatment of ischemic strokes by the American Stroke Association.
Generally speaking, there are two types of strokes that can occur—ischemic stroke or hemorrhagic stroke. An ischemic stroke occurs when there is an obstruction to one of the vessels that supplies blood to the brain. A hemorrhagic stroke occurs when a blood vessel ruptures and bleeds into the area surrounding the brain. T.P.A. can only be used to treat ischemic strokes. When timely used to treat an ischemic stroke, it can be a brain-saving treatment.
RECENT STUDIES SHOW TPA CAN PREVENT BRAIN INJURY AFTER A STROKE BUT SKEPTICS SAY TPA IS DANGEROUS
In 2011, Oriana Sousa, a Portuguese psychologist who is now 28 year-old was diagnosed with a rare form of ovarian cancer. When the symptoms started doctors initially failed to diagnose the cancer. For several months Oriana suffered from frequent constipation and fatigue. She was also thirsty all the time. Then she started to have terrible abdominal pain and began vomiting. Her doctor told her she was fine and she shouldn’t worry. Her aunt who is a nurse recommended that she see visit another doctor. The new doctor performed a CT scan and found a massive tumor. Oriana was diagnosed with a very rare, aggressive and fatal form of ovarian cancer.
Immunotherapy shrank the tumor to the surprise of the doctors
During several years Oriana went through surgery, chemotherapy and radiotherapy to try to eradicate the tumor however new tumors would grow back. Then Oriana convinced her doctor to give her nivolumab, an immunotherapy drug that was not supposed to be used on her tumor. The tumor reacted immediately and shrank. As she continued to take the drug the tumor shrank to the point that she has no more evidence of the disease. Now doctors and researchers are trying to figure out why they were wrong.
Medical Malpractice may have been committed on many American Africans who were previously diagnosed with hypertrophic cardiomyopathy. A recent study found that some genetic variations that were linked to this condition were indeed harmless. These specific genetic variations were found more often in black Americans than in white Americans. Therefore many patients from African descent may have been misdiagnosed or are still being treated for a condition they don’t suffer from.
Also called, abnormally thick heart muscle, hypertrophic cardiomyopathy is a genetic disease that affects 1 out of 500 Americans. The disorder can cause arrhythmia and can be fatal. Symptoms may include chest pain, difficulty, breathing, fatigue and swelling in the ankles and feet. For a complete list and diagnostic testing see The American Heart Association web site. Sometimes there are no symptoms.
Abnormally thick heart muscle is diagnosed through genetic testing. A patient who tests positive for the condition will often be required to change his or her lifestyle. These changes may include healthy diet, additional physical activities, losing excessive weight or stopping smoking. Patients diagnosed with hypertrophic cardiomyopathy are often prescribed specific medication to treat the condition. Various types of surgeries are also commonly used as well as alcohol septal ablation, a noninvasive procedure.
Failure to diagnose alcohol withdrawal symptom (AWS) can be medical malpractice that may cause severe injury or even death in some cases. The ECRI Institute is looking at options to better “Identify Alcohol Withdrawal Symptoms Early and Ease Patients’ Care”.
An estimated 20 % of the patients that are admitted in US hospitals show symptoms of alcohol abuse or dependence. Those that are admitted for alcohol poisoning and detoxification may be difficult to treat but their alcohol withdrawal symptoms will usually be properly diagnosed and addressed.
Patients at a higher higher risk to be misdiagnosed for alcohol withdrawal symptoms are those who are admitted for a different medical condition than alcohol intoxication or dependence.
Failure to diagnose or delay to treat a bacterial infection in a newborn can be medical malpractice. Doctors (and also parents) may sometimes be reluctant to submit a young infant to a lengthy and complicated process in order to find out if a fever may be caused by a bacterial infection. Thanks to new research this process may become much easier in the future.
Fever is usually one of the first symptom of a bacterial infection. However it can also be caused by other medical conditions. When a health care provider evaluates a young infant with fever and suspect an infection, there is no quick way to find out if the infant suffers from a bacterial infection. The actual method consists in isolating live bacteria from blood, urine or spinal fluid and grow a bacteria culture in a laboratory. This may require difficult and traumatizing medical procedures such as spinal tap. Additionally the infant may necessitate hospital admission and an antibiotic prescription until the results of the tests are available.
A recent study that was published on Aug. 23, 2016 in the Journal of the American Medical Association found that through advances in genetic sequencing technology it may soon be possible for doctors to diagnose bacterial infections in infants with fevers quickly and in a non invasive manner. More work is needed but in the future only a small blood sample may be enough to immediately determine if an infant suffers or not from a bacterial infection.
Although very rare, failure to diagnose and treat desmoids tumors, also called aggressive fibromatosis, a tumor that develops in the fibrous tissue that forms tendons and ligaments, can be medical malpractice. Desmoids tumors are very rare and difficult to diagnose and doctors are still debating what is the most appropriate categorization and treatment. In a recent article in the Washington Post, Sandra G. Boodman writes about a 24 year woman who suffered several episodes of excruciating stomach pain before being diagnosed and treated for a desmoid tumor.
Johanna Dickson was 23 years old when the first symptoms of the disease occured. She had just come back from South Africa when she suffered a first episode of acute abdominal pain. She thought she caught some type of stomach bug in her last trip. The family doctor sent her to the hospital for various tests but nothing was found and the pain disappeared.
Another crisis happened six months later but it went away quickly so she didn’t even bother to see a doctor.
Failure to timely diagnose Denys-Drash syndrome can be medical malpractice that can lead to renal failure and ultimately death. Denys-Drash syndrom is a very rare congenital disorder that affects young children. There are only 150 known cases in the world therefore very little information is available for doctors to diagnose and treat this disorder.
What is known so far is that 90% of the children with this disorder develop a rare pediatric kidney cancer known as Wilms tumor. Undescended testes and severe proximal hypospadias are also associated with this disorder. The Journal of the American Academy of Physician Assistants (JAAPA) recently released an article describing the case of a 3 year old patient affected by this syndrome. The authors Shawn C. Smith, Barry Chang and Laura Beth Fleming are all from the Cardon Children Medical Center in Mesa, AZ where the patient was admitted. The article describe how the authors of the article diagnosed the disorder and which treatments were used to treat the patient. The complete article can be found here